The global Barrett's Esophagus with Dysplasia (BED) market is experiencing significant growth, propelled by the rising prevalence of GERD - a key precursor to BED - and increased awareness of ...

Perelman School of Medicine conducted a study of endoluminal therapy, an endoscopy-based treatment, on patients with Barrett’s esophagus or in the early stages of cancer and found that neoplasia was ...

Surgery, specifically an esophagectomy (removal of part or all of the esophagus and surrounding lymph nodes), is a common ...

La Peer Health Systems in Beverly Hills, Calif., has announced it is offering a new treatment for Barrett’s esophagus, according to a news release. Physicians in the surgery center’s department of ...

Blitzkrieg for Barrett's Esophagus Containing Early Neoplasia For Barrett's esophagus with early neoplasia, radiofrequency ablation combined with endoscopic resection represents the current ...

It is evident that Barrett's esophagus, a pathophysiologic condition affecting the gastroesophageal junction and lower esophagus, progresses to adenocarcinoma of the esophagus in some patients. Indeed ...

Thomas Jefferson University Hospital in Philadelphia has announced it has opened a new Barrett’s esophagus treatment center, according to a news release. The Jefferson Barrett’s Esophagus Treatment ...

Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 September). PromarkerEso is a world-first protein biomarker-based blood diagnostic that can rule out ...

A new treatment for Barrett’s esophagus, a pre-cancerous condition associated with chronic gastroesophageal reflux disease, which may prevent esophageal cancer, was performed at Longview (Texas) ...

A team led by researchers at Baylor College of Medicine and Washington University School of Medicine has shed light on the process that drives Barrett’s esophagus formation. This condition affects the ...

Please provide your email address to receive an email when new articles are posted on . A capsule-sponge test may help risk-stratify patients with Barrett’s esophagus. Patients classified as low risk ...

FRIENDSWOOD, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new ...